
© 2025 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
32,600 | 33,800 | 17.04. | |
0,000 | 0,000 | 31.08.22 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11.04. | Goldman Sachs maintains Neutral on CRISPR Therapeutics stock | ||
11.04. | Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? | ||
04.04. | Crispr Therapeutics gets orphan drug status for lymphoma treatment | ||
04.04. | Crispr Therapeutics erhält Orphan-Drug-Status für Lymphom-Behandlung | ||
03.04. | Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March |